Metraipolis › archive › dc_d44e41c3bc00
PARP Inhibitors in Metastatic Prostate Cancer: Bridging Biomarker Complexity and Clinical Decision-Making Through a Pragmatic Treatment Framework — Europe PMC PMID:42352483
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42352483
- DOI
- 10.3390/cancers18121949
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T09:38:58.545Z
- SHA-256 of the archived text
6859e42164c23074892dd088b9f125d6234f14d4785260dab668f10fc19280bc- Stable URL of this page
https://metraipolis.com/documento/dc_d44e41c3bc00
How to cite
PARP Inhibitors in Metastatic Prostate Cancer: Bridging Biomarker Complexity and Clinical Decision-Making Through a Pragmatic Treatment Framework — Europe PMC PMID:42352483 — Europe PMC (en), https://europepmc.org/article/MED/42352483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d44e41c3bc00 (Metraipolis archive dc_d44e41c3bc00, sha256 6859e42164c23074892dd088b9f125d6234f14d4785260dab668f10fc19280bc)
BibTeX
@misc{dcd44e41c3bc00,
title = {PARP Inhibitors in Metastatic Prostate Cancer: Bridging Biomarker Complexity and Clinical Decision-Making Through a Pragmatic Treatment Framework — Europe PMC PMID:42352483},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42352483},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d44e41c3bc00; sha256 6859e42164c23074892dd088b9f125d6234f14d4785260dab668f10fc19280bc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42352483. Agents can read the archived copy with the MCP tool read_document.